Extension Study of Protocol ENB-002-08 - Asfotase Alfa Treatment in Severely Affected Infants and Young Children With Hypophosphatasia (HPP)
This study is ongoing, but not recruiting participants.
Sponsor:
Alexion International Sàrl
Information provided by (Responsible Party):
Alexion International Sàrl
ClinicalTrials.gov Identifier:
NCT01205152
First received: September 17, 2010
Last updated: January 24, 2013
Last verified: July 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2014 |
| Estimated Primary Completion Date: | December 2014 (Final data collection date for primary outcome measure) |